Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00836758 · ClinicalTrials.gov registry record · NA

Comparison of Breathing Event Detection by a Continuous Positive Airway Pressure Device to Clinical Polysomnography

A NA study of Sleep Apnea, sponsored by Philips Respironics.

Completed
Registry status
NA
Development phase
115
Enrollment target
1
Study location

NCT00836758: Completed NA study of Sleep Apnea, sponsored by Philips Respironics.

NCT00836758 is a NA study of Sleep Apnea that has completed, run by Philips Respironics. The registered enrollment target is 115 participants, below the 2,986-participant average among 36 other Sleep Apnea trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00836758, a NA study of Sleep Apnea, has completed, sponsored by Philips Respironics.

COMPLETED
Registry status
NA
Development phase
115 participants
Enrollment target
1
Study location

Study Summary

The study is to compare the performance of a CPAP (continuous positive airway pressure) device to a clinical polysomnography (PSG) in identifying breathing events in patients with obstructive sleep apnea.

Primary Outcome

Apnea-hypopnea index (AHI) is the combined average number of apneas and hypopneas that occur per hour of sleep. The Apnea index (AI) is the average number of apneas that occur per hour of sleep. The Hypopnea index (HI) is the average number of hypopneas that occur per hour of sleep. The PSGs were manually scored to determine the apnea-hypopnea index. This value was then compared to the PAP device which utilized the AED algorithm to determine the apnea-hypopnea index.

Conditions Studied

Interventions

  • DEVICE Analysis with AED and manual PSG scoring

Study Locations (1)

Florida

  • Shands and UF Sleep Disorder Center - Gainesville

Trial Details

FieldValue
Enrollment Target 115 participants
Start Date 2009-02
Est. Completion 2009-08
Phase NA
Philips Respironics

35 total trials

What the finished NCT00836758 record still lists

NCT00836758 is an interventional study that assigns participants to a tested intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap, below the 2,986-participant average among 36 other Sleep Apnea trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which Analysis with AED and manual PSG scoring is the first listed.

NCT00836758 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT00836758 about?

NCT00836758 is a clinical study titled "Comparison of Breathing Event Detection by a Continuous Positive Airway Pressure Device to Clinical Polysomnography". The study is to compare the performance of a CPAP (continuous positive airway pressure) device to a clinical polysomnography (PSG) in identifying breathing events in patients with obstructive sleep apnea.

What is the current status of trial NCT00836758?

This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2009-02. Estimated completion is 2009-08.

What conditions does trial NCT00836758 study?

This clinical trial studies the following conditions: Sleep Apnea.

What interventions are being tested in trial NCT00836758?

The interventions under investigation include: Analysis with AED and manual PSG scoring (DEVICE).

Who is sponsoring clinical trial NCT00836758?

This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00836758 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00836758's enrollment target sits among peer trials

115 15th of 36 higher than 22 of 36 other Sleep Apnea trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02346929 · 115 participants · NA

    Hematoma Block for Distal Radius Fracture

  • NCT03394365 · 115 participants · Phase 3

    A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

  • NCT03907475 · 115 participants · Phase 2

    Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial

  • NCT05086692 · 115 participants · Phase 1

    A Beta-only IL-2 ImmunoTherapY Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00836758, the US trial registry maintained by the National Library of Medicine. NCT00836758 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.